User Warns of Potential Blindness Linked to Ozempic Use

WHO:

NY Post - Todd Engel, 63, is the individual claiming vision loss.

Fox News - Todd Engel has filed a lawsuit against Novo Nordisk.

WHAT:

NY Post - Engel was prescribed Ozempic to manage his diabetes.

Fox News - Engel claims that Ozempic caused his total vision loss from NAION (non-arteritic anterior ischemic optic neuropathy).

Fox News - Engel is sharing a warning for other users regarding the potential risks of Ozempic.

WHERE:

NY Post - The incident involving Engel occurred in Maryland.

WHEN:

NY Post - Engel was first prescribed Ozempic in 2023.

WHY:

Fox News - Engel alleges that the drug warnings provided by Novo Nordisk were inadequate.

HOW:

Fox News - Engel's lawsuit claims that the use of Ozempic led to his vision loss.

(UPDATED October 16, 2026 08:00 UTC)

Todd Engel, a 63-year-old from Maryland, has filed a lawsuit against Novo Nordisk, claiming that the diabetes medication Ozempic caused him to suffer total vision loss due to non-arteritic anterior ischemic optic neuropathy. Engel, who was prescribed Ozempic in 2023, alleges that the warnings provided by the company were inadequate and is now sharing a warning for other users about the potential risks associated with the drug. His lawsuit highlights the serious consequences he attributes to the use of Ozempic, emphasizing the need for clearer communication regarding its side effects.